tiprankstipranks
Advertisement
Advertisement

MRNA Stock Latest News

Moderna price target raised to $120 from $67 at Goldman Sachs
The FlyModerna price target raised to $120 from $67 at Goldman Sachs
2h ago
MRNA
BofA upgrades Moderna to Neutral on ‘fundamentally changed’ story
PremiumThe Fly
BofA upgrades Moderna to Neutral on ‘fundamentally changed’ story
3h ago
MRNA
Moderna upgraded to Neutral from Underperform at BofA
PremiumThe Fly
Moderna upgraded to Neutral from Underperform at BofA
3h ago
MRNA
Short Sellers Lose $4.8 Billion as Moderna Stock (MRNA) Soars 150%
PremiumMarket News
Short Sellers Lose $4.8 Billion as Moderna Stock (MRNA) Soars 150%
3h ago
MRNA
JPMorgan Weighs In on Moderna Stock Amid 140%-Plus Jump (And It Ain’t Pretty)
PremiumMarket News
JPMorgan Weighs In on Moderna Stock Amid 140%-Plus Jump (And It Ain’t Pretty)
3h ago
MRNA
Tempus AI Stock (TEM) Is Surging 24% on Wednesday – Here’s Why
PremiumMarket NewsTempus AI Stock (TEM) Is Surging 24% on Wednesday – Here’s Why
3h ago
MRK
TEM
Moderna Stock (MRNA) Soars 133%; Five-Star William Blair Analyst Says Strong Cancer Data Could Be a Game-Changer
Premium
Market News
Moderna Stock (MRNA) Soars 133%; Five-Star William Blair Analyst Says Strong Cancer Data Could Be a Game-Changer
4h ago
MRK
MRNA
Moderna rises 128.3%
Premium
The Fly
Moderna rises 128.3%
4h ago
MRNA
Moderna data bode well for Sellas into imminent readout, says Maxim
PremiumThe Fly
Moderna data bode well for Sellas into imminent readout, says Maxim
5h ago
SLS
MRNA
Moderna price target raised to $130 from $45 at RBC Capital
PremiumThe Fly
Moderna price target raised to $130 from $45 at RBC Capital
5h ago
MRNA
Leerink says cancer vaccine win should sustain Merck momentum into fall
PremiumThe Fly
Leerink says cancer vaccine win should sustain Merck momentum into fall
6h ago
MRK
BNTX
Pfizer (PFE) Stock Rallies 4% Thanks to Merck (MRK) and Moderna (MRNA)’s Cancer Trial Update
PremiumMarket News
Pfizer (PFE) Stock Rallies 4% Thanks to Merck (MRK) and Moderna (MRNA)’s Cancer Trial Update
6h ago
MRK
PFE
Moderna rises 113.6%
PremiumThe FlyModerna rises 113.6%
6h ago
MRNA
Phase 3 Melanoma Success Strengthens Moderna’s Oncology Outlook, But Risk‑Reward Keeps Analyst at Hold
Premium
Ratings
Phase 3 Melanoma Success Strengthens Moderna’s Oncology Outlook, But Risk‑Reward Keeps Analyst at Hold
6h ago
MRNA
Early notable gainers among liquid option names on August 19th
Premium
The Fly
Early notable gainers among liquid option names on August 19th
6h ago
EL
MRK
Moderna upgraded, Baidu downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Moderna upgraded, Baidu downgraded: Wall Street’s top analyst calls
7h ago
D
ZM
Why Moderna Stock Is Rallying Today — and What Wall Street Expects Next
PremiumMarket News
Why Moderna Stock Is Rallying Today — and What Wall Street Expects Next
7h ago
MRNA
Video: Moderna skyrockets after cancer vaccine shows promise in Phase 3 trial
PremiumThe Fly
Video: Moderna skyrockets after cancer vaccine shows promise in Phase 3 trial
7h ago
LOW
MRK
Stifel sees Moderna data as positive for Repligen, Maravai
PremiumThe Fly
Stifel sees Moderna data as positive for Repligen, Maravai
7h ago
MRNA
MRVI
Wells sees Repligen among key beneficiaries of Moderna’s cancer vaccine data
PremiumThe FlyWells sees Repligen among key beneficiaries of Moderna’s cancer vaccine data
7h ago
DHR
MRK
Citi says questions remain on efficacy after Moderna data
Premium
The Fly
Citi says questions remain on efficacy after Moderna data
7h ago
MRK
MRNA
Morning Movers: Moderna skyrockets, Merck up after INTerpath-001 trial results
Premium
The Fly
Morning Movers: Moderna skyrockets, Merck up after INTerpath-001 trial results
7h ago
EL
ADI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >